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Abstract The three surface tryptophans of the Type IIa
cellulose binding domain of Pseudomonas fluorescens subsp.
cellulosa xylanase A (CBDXYLA) were independently mutated to
alanine, to create the mutants W13A, W49A and W66A. The
three mutant proteins were purified, and their capacity to bind to
a variety of ligands was determined. The mutant proteins have
native-like structures but exhibited much weaker affinity for
crystalline and amorphous cellulose and for cellohexaose than the
wild type. These data indicate that all three tryptophans are
important for binding to cellulose, and support a model in which
the three tryptophans form an aromatic strip on the surface of
the protein that binds to a single cellulose.
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1. Introduction
The L-1,4-glycosidic bonds in cellulose and xylan, the most
abundant polysaccharides in the biosphere, are hydrolysed by
cellulases and xylanases, respectively. The molecular architec-
tures of these enzymes are complex. In general, they have a
modular structure consisting of discrete structural and func-
tional domains [1,2]. Many cellulases and xylanases contain a
catalytic domain and one or more non-catalytic cellulose
binding domains (CBDs; [1,2]). Several studies have shown
that CBDs potentiate the catalytic activity of cellulases
against crystalline substrates, and xylanases against cellulose/
xylan complexes; however, these domains do not potentiate
the activity of glycosyl hydrolases against soluble substrates
[3^8]. The mechanism by which CBDs potentiate plant cell
wall hydrolase activity is unclear. Din et al. [4,5] have shown
that CBDs from Cellulomonas enzymes can disrupt the struc-
ture of cellulose micro¢brils, and can increase the activity of
cellulases in trans, suggesting that these domains increase the
accessibility of the substrate to enzyme attack by disrupting
the surface of cellulose micro¢brils. In contrast, Bolam et al.
[8] have shown that the CBDs from Pseudomonas cellulases
and xylanases do not appear to disrupt the structure of cellu-
lose micro¢brils or the integrity of the plant cell wall, and do
not potentiate cellulase or xylanase activity in trans. Thus, it
has been suggested that the Pseudomonas CBDs potentiate
plant cell wall hydrolases by increasing enzyme-substrate
proximity.
In bacteria, the majority of CBDs is highly conserved, and
has been classi¢ed as Type II domains [1]. Recently, the three
dimensional structure of the Type II CBD from Cellulomonas
¢mi Cex (CBDCex) has been solved by nuclear magnetic reso-
nance (NMR) [9]. The ligand binding region of CBDCex was
suggested to contain W54 and W72, which are adjacent and
exposed on the surface, and possibly W17 which is also sur-
face-exposed, but separated from W54 and W72. Site-directed
mutagenesis studies of a similar Type II CBD, from C. ¢mi
CenA, showed that the equivalent residues to CBDCex W72
and W17 play an important role in the interaction of the
domain with crystalline cellulose [10]. In contrast, Poole et
al. [11] showed, in a qualitative assay, that when W66A or
W66F (the equivalent residue to W72 in CBDCex) mutants of
the Type II CBD from Pseudomonas £uorescens subsp. cellu-
losa xylanase A (CBDXYLA) were fused to alkaline phospha-
tase, without a linker sequence separating the two proteins,
the fusion polypeptide retained signi¢cant a⁄nity for crystal-
line cellulose (Avicel). This led to the suggestion that W66
does not play an important role in cellulose binding in
CBDXYLA, and that the function of conserved tryptophan
residues in Type IIa CBDs varies in di¡erent proteins. How-
ever, the data of Poole et al. must be viewed with some cau-
tion as the assays were only qualitative, and the e¡ect on the
interaction of the CBD with cellulose, of fusing the CBDXYLA
to a heterologous protein is unknown.
In addition to studies focusing on the interaction of CBDs
with insoluble ligands, the binding of these proteins to oligo-
saccharides has also been investigated. Thus, NMR analysis
of cellohexaose titrations of CBDCex showed that the ligand
had a signi¢cant e¡ect on the chemical shift of W72 and W54,
but only a very small e¡ect on the chemical shift of W17 [9].
The authors concluded that W54 and W72 play a central role
in binding cellohexaose, while W17 might be less important
for cellohexaose binding but could participate in the binding
of longer L-1,4-glucans in cellulose [9]. The titration of
CBDXYLA with cellohexaose produced similar results ; the
chemical shifts of two tryptophan residues were signi¢cantly
a¡ected on binding of the oligosaccharide, while the chemical
shift of a third tryptophan was only very slightly a¡ected by
the ligand [8].
Although the data described above suggest that the binding
of cellohexaose to CBDCex and CBDXYLA is broadly similar, it
is unclear whether the tryptophan residue, whose chemical
shift is only slightly a¡ected by the oligosaccharide, is playing
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an important role in binding cellohexaose. In addition, it re-
mains to be established whether the data from the W66A
CBDXYLA-alkaline phosphatase fusion protein [11] provided
a true picture of the importance of W66 in the binding of
the CBDXYLA to insoluble cellulose. To resolve these ques-
tions we have substituted alanine for each of the tryptophan
residues in CBDXYLA, which correspond to the surface tryp-
tophans in CBDCex (the CBDXYLA residues W13, W49, and
W66 correspond to the CBDCex residues W17, W54 and W72,
respectively) and have investigated the capacity of the mutant
proteins, expressed as discrete entities, to bind to various lig-
ands. The data show that all three tryptophan residues play
an important role in binding both cellohexaose and insoluble
cellulose. Thus, although the chemical shift of W13 (equiva-
lent to W17 in CBDCex) is largely una¡ected by CBDXYLA
binding to cellohexaose, this residue does play an important
role in the interaction between the protein domain and the
oligosaccharide.
2. Materials and methods
2.1. Bacteria, vectors and culture media
Escherichia coli BL21 (DL3) containing pLysS, obtained from No-
vagen, was used as the host for expressing CBDXYLA. The region of
the Pseudomonas xylanase A gene (xynA ; [8]) encoding CBDXYLA was
cloned into NdeI/BamHI-restricted pET16b (Novagen) and the re-
combinant plasmids generated were transformed into BL21 (DE3)
pLysS to express the CBD. The conditions used to culture the re-
combinant strains and the subsequent puri¢cation of the CBD were
described previously [8]. Puri¢ed native and mutant forms of
CBDXYLA were homogeneous as judged by SDS-PAGE [12].
2.2. Construction of CBDXYLA mutants
Mutants of the CBDXYLA were generated by the transformer meth-
od (Clonetec). The target DNA molecule was recombinant pET16b
containing the region of xynA [8] encoding CBDXYLA. The selection
primer was designed to destroy the ScaI restriction site in the bla
gene of pET16b. The mutagenic primers used to generate the appro-
priate mutations in xynA were as follows: W13A, 5P-ATTACCAAC-
GAAGCGAACACGGGCTAT-3P ; W49A, 5P-CTCAGTAGTAGCG-
CGAATGCCAACGTG-3P ; W66A, 5P-TCAAACCTGAGCGCGAA-
TGGCAATATC-3P. The nucleotides in bold are the mutations intro-
duced into the target DNA sequence. The region of xynA encoding
the mutant forms of CBDXYLA cloned into pET16b was sequenced
using an ABI 373 DNA sequenator, to ensure that only the desired
mutations were incorporated into the Pseudomonas sequence.
2.3. Biochemical analysis of CBDXYLA
The capacity of native and mutant forms of CBDXYLA to bind to
insoluble cellulose was determined by performing binding isotherms
using amorphous cellulose (acid swollen cellulose) and crystalline cel-
lulose (bacterial microcrystalline cellulose; BMCC) as the ligands.
Details of how these binding isotherms were conducted are described
previously [8]. The capacity of the di¡erent forms of the CBDXYLA to
bind to cellohexaose was determined from 1D NMR spectra of the
CBDs titrated with increasing concentrations of cellohexaose, as de-
scribed previously [8].
3. Results and discussion
3.1. Interaction of CBDXYLA mutants with insoluble cellulose
To investigate the importance of W13, W49 and W66 in the
capacity of CBDXYLA to bind to di¡erent forms of cellulose,
the following three mutants of the protein domain were con-
structed: W13A, W49A and W66A. Native and mutant forms
of the CBD were puri¢ed as described previously [8], and the
capacity of the four proteins to bind to insoluble forms of
cellulose was investigated. The data, presented in Table 1,
show that all three mutants exhibit very low a⁄nities for
both amorphous and crystalline cellulose compared to the
native protein. These data are consistent with the study of
Din et al. [10], which showed that the equivalent residues to
W13 and W66, in C. ¢mi CenA, also played a critical role in
the capacity of the domain to bind to crystalline cellulose. The
results are also in agreement with the location of the equiv-
alent three residues in the ligand binding site of CBDCex ; the
three tryptophan side chains are co-planar, and are likely to
form strong hydrophobic interactions with the glucose pyra-
nose rings in the cellulose molecules situated in the site [9].
Interestingly, the results presented above contradict a pre-
vious study by Poole et al. [11] which showed, in a qualitative
assay, that when W66A or W66F mutants of CBDXYLA were
fused to alkaline phosphatase, without a linker sequence sep-
arating the two proteins, the fusion polypeptide retained sig-
ni¢cant a⁄nity for crystalline cellulose (Avicel). This led to
the suggestion that W66 does not play an important role in
cellulose binding by CBDXYLA. In view of the positioning of
this tryptophan residue in CBDCex, the loss of binding ob-
served when it is mutated in CBDCenA or CBDXYLA (expressed
as discrete domains), and the high degree of conservation of
this aromatic amino acid in Type II CBDs, we suggest that
W66 does play a critical role in the binding of CBDXYLA to
insoluble cellulose. The previous study of Poole et al. [11] in
which the CBDs were fused to alkaline phosphatase did not
re£ect the true cellulose-binding capacity of the mutated
CBDs. It is apparent, therefore, that when analysing the struc-
tural basis for the ligand binding of CBDs, these domains
should be studied either as discrete entities, or as components
of the original protein, but not when fused to a heterologous
polypeptide.
3.2. Identi¢cation of W13, W49 and W66 in the NMR
spectrum of CBDXYLA
Previously, we showed that when CBDXYLA binds to cello-
hexaose, there is a signi¢cant change in the chemical shifts of
two tryptophans (at 10.13 ppm) and a small change in the
chemical shift of a third tryptophan (at 10.00 ppm) [8]. To
assign these three tryptophans, the NMR spectra of the native
and mutant proteins were compared (Fig. 1). Most signals in
the spectra of the mutant proteins are in the same place as in
the native protein, demonstrating that the mutant proteins are
folded correctly and have no signi¢cant conformational di¡er-
ences from the native protein. The data in Fig. 1 show that
the tryptophan signal at 10.00 ppm in the native protein is not
present in the W13A mutant protein, and can therefore be
assigned to W13. A tryptophan signal at 10.39 ppm is present
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Table 1
A⁄nity of native and mutant forms of CBDXYLA for insoluble cel-
lulose
CBDXYLA Binding a⁄nities (Ka)a





aKa values were determined from binding isotherms essentially as
previously described [8]. The a⁄nities are expressed as 106 M31.
bAmorphous cellulose is generated from acid swollen Avicel.
cCrystalline cellulose is bacterial microcrystalline cellulose.
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in native and mutant proteins, and is assigned to either W34
or W38. The two overlapping signals at 10.13 ppm are shifted
slightly in W13A, and one is missing in both W49A and
W66A. Therefore the signals at 10.13 ppm have been assigned
to W49 and W66. The changes in chemical shift seen in the
mutants are consistent with the close proximity of W49 and
W66 in the NMR structure of CBDCex, which means that
removal of one tryptophan a¡ects the signals from the other.
A similar argument applies to changes a¡ecting W13, which is
close to W49.
These assignments show that the signals undergoing a large
chemical shift change on titration of native protein with cel-
lohexaose are from W49 and W66, and the signal undergoing
a smaller chemical shift change is from W13. The results (and
those of the binding studies presented above) are consistent
with those of Xu et al. [9] on CBDCex, and suggest that the
structures of the Type IIa CBDXYLA and CBDCex are highly
conserved and do not change signi¢cantly on addition of cel-
lulooligosaccharides, and that the location and function of
W13, W49 and W66 in CBDXYLA are equivalent to those of
W17, W54 and W72, respectively, in CBDCex.
3.3. Importance of W13 in the binding of CBDXYLA
to cellohexaose
Although the data described above clearly implicate W13,
W49 and W66 in binding CBDXYLA to insoluble cellulose, the
very small change in the chemical shift of W13 (and its equiv-
alent W17 in CBDCex) calls into question the importance of
this residue in binding soluble cellulooligosaccharides. For
this reason, Xu et al. [9] suggested that it may rather be in-
volved in the binding of longer L-1,4-glucans (or possibly
parallel cellulose chains in cellulose ¢brils). To investigate
the importance of W13 in the binding of CBD to cellohex-
aose, native and mutant CBDXYLA were titrated with cello-
hexaose, and the NMR spectra of the proteins were recorded.
The results (Fig. 2) show that, when any one of the three
surface tryptophans is mutated to alanine, the chemical shift
changes of the remaining two are much smaller than they are
in the native protein. These results imply that all three tryp-
tophans are required for good binding to cellohexaose, and
that the binding site encompasses all three tryptophans (or the
remaining two when one is mutated out). This conclusion is
sterically plausible, since in CBDCex W17 and W72 are about
30 Aî apart, which is the same as the separation between the
terminal saccharide units of cellohexaose [13]. Furthermore,
the conclusion is in agreement with the model presented by
Tormo et al. [13], which proposes that the three surface ex-
posed tryptophan residues in CBDs act as a planar binding
strip for a single cellulooligosaccharide chain.
Several NMR studies have shown that there is no direct
relationship between the magnitude of chemical shift changes
and binding strength. This study shows that W13 appears to
be as important as W49 or W66 to cellohexaose or cellulose
binding to CBDXYLA, even though its chemical shift changes
are much smaller. The chemical shift of Trp NHY can be
a¡ected by neighbouring aromatic rings, peptide bonds or
hydrogen bonds, and is highly sensitive to small changes in
local geometry, in a way that is not easily predictable [14],
implying that the magnitude of a chemical shift change should
be interpreted with caution.
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Fig. 1. NMR spectra of native and mutant forms of CBDXYLA. Proteins were all approximately 0.7 mM in 50 mM sodium phosphate bu¡er,
pH 7.0, 30‡C. The spectra were acquired on a Bruker DRX 500 spectrometer and 1H shifts were referenced to TSP as an internal standard at
0 ppm. The spectra show the low-¢eld region of the NMR spectrum: the other regions of the spectra are almost identical to each other. Spec-
tra of native protein at di¡erent temperatures show that there are two tryptophan signals at 10.13 ppm; 2D total correlated spectroscopy
(TOCSY) demonstrated that the signals at 11.27 and 10.00 ppm are from alanine and threonine backbone amide protons, respectively.
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To conclude, the data presented in this study have clari¢ed
the role of the tryptophan residues located on the surface of
Type IIa CBDs. It is apparent that the pivotal role of these
residues in the binding of CBDs to both crystalline cellulose
FEBS 20389 18-6-98
Fig. 2. Titrations of native and mutant forms of CBDXYLA with cellohexaose. Spectra show the regions of the NMR spectra of wild-type,
W13A, W49A and W66A (all ca. 0.7 mM) that contain the tryptophan NH? signals for W13, W49 and W66, with (from top to bottom) in-
creasing amounts of cellohexaose, up to about 25 equivalents in each case. To guide the eye, vertical lines have been drawn through each sig-
nal. Dashed lines indicate signals that are not a¡ected by the addition of cellohexaose, while solid lines indicate signals that move on addition
of cellohexaose. Chemical shift changes in all three mutants are smaller than in the wild type.
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and soluble oligosaccharides, is conserved in a range of Type
IIa CBDs. There is no evidence to suggest that the function of
these aromatic amino acids varies depending on the origin of
the Type IIa domain, as suggested previously [1,8,11].
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